How to Value a Dental Specialty Practice: Endodontics, Periodontics, and Oral Surgery

Most dental valuation advice is written for general dentists, and it doesn't translate well to specialists. I learned this the hard way early in my career when I tried to apply standard collections-based methods to an oral surgery practice and came up with a number that was less than half what the practice eventually sold for. Specialty practices have fundamentally different economics, referral dynamics, and buyer pools.

Let me break down how each major dental specialty is valued in 2026, because the differences between them are as significant as the difference between general dentistry and any specialty.

Oral Surgery: The Highest Multiples in Dentistry

Oral and maxillofacial surgery practices command the highest valuations in the dental world — and it's not close. Multi-provider OMS practices are trading at 7-14x EBITDA, with well-run groups regularly closing above 10x. Solo OMS practices sell for 4-7x SDE, well above the 1.5-2.5x range for general dentists selling to individual buyers.

Why? Three reasons that compound on each other.

Procedure complexity creates barriers to entry.An oral surgeon completes 4-6 years of residency after dental school. They perform extractions, wisdom teeth removal, dental implants, jaw surgery, bone grafting, and facial trauma repair. Many are dual-degree (MD/DMD) and credentialed at hospitals. You can't just hire a new grad to replace this skillset — and buyers know it.

Anesthesia capability is a moat. OMS practices with in-office IV sedation and general anesthesia licensing have a capability that general dentists and most other specialists lack. This creates a natural referral pipeline: every general dentist in a 15-mile radius sends their surgical cases to you. An OMS practice with a well-established referral network of 80-150 referring dentists has effectively locked in a patient acquisition channel that costs almost nothing to maintain.

DSOs and PE firms are aggressively acquiring. MB2 Dental, USOSM (US Oral Surgery Management), and several PE-backed platforms are building oral surgery networks. USOSM, backed by Kohlberg & Company, has acquired 100+ OMS practices and pays premium multiples for multi-doctor groups with $2M+ EBITDA. These platform builders pay 10-14x EBITDA for anchor acquisitions and 7-9x for bolt-ons.

A three-surgeon OMS practice I worked with last year — $6.5M in revenue, $1.8M EBITDA, two locations, hospital privileges at three systems — closed at 11.2x EBITDA with a PE-backed oral surgery platform. The key differentiator was their implant volume: they were placing 400+ implants per year, and the buyer saw an opportunity to add guided surgery and same-day implant protocols to increase per-case revenue.

Endodontics: Referral-Dependent and Microscope-Critical

Endodontic practices (root canal specialists) are valued at 3-5x SDE for solo practitioners and 5-8x EBITDAfor multi-provider groups. That's meaningfully lower than oral surgery, and the reason is straightforward: the referral dynamic is more fragile.

An endodontist's entire patient flow comes from general dentist referrals. Unlike oral surgery, where the complexity of the procedure makes self-referral impractical, general dentists are increasingly doing their own root canals — especially with rotary endodontic systems and CBCT imaging becoming standard in GP offices. This means an endodontist's referral network can erode over time as GPs retain easier cases.

What separates premium endodontic practices from average ones:

• Microscope-equipped operatories. Practices with surgical operating microscopes (Zeiss, Global, Leica) in every treatment room command a 15-25% premium. The microscope enables retreatment cases and microsurgery (apicoectomies) that generate $1,500-$2,500 per case vs. $800-$1,200 for standard root canals.
• CBCT imaging on-site. Cone beam CT allows 3D visualization of complex canal anatomy. Practices with in-house CBCT can charge $150-$300 for the scan and make better treatment decisions, improving case acceptance and outcomes.
• Referral breadth. A practice receiving referrals from 100+ general dentists is far more durable than one dependent on 15-20 referring offices. If your top 5 referral sources represent more than 40% of your cases, that's a concentration risk buyers will discount.
• Case volume per provider. Efficient endodontists complete 8-12 cases per day. If your providers are at 5-6 cases per day, buyers see either inefficiency or weak demand — both reduce value.

Typical endodontic practice economics: $800K-$1.5M revenue per provider, 35-45% overhead ratio, $400K-$600K SDE for a solo practitioner. A well-run solo endodontic practice collecting $1.2M with $500K SDE would sell for $1.5M-$2.5M to another endodontist, or potentially $2M-$3M if a DSO with an endodontic strategy is the buyer.

Periodontics: The Implant Pivot Changes Everything

Periodontal practices in 2026 are in a state of transformation, and the valuation reflects it. Traditional perio (scaling and root planing, gum surgery, maintenance) is a declining revenue category as more GPs handle routine perio in-house. But practices that have successfully pivoted to implant placement as a primary service line are thriving.

The valuation split is stark:

• Traditional perio-focused practices: 2-3.5x SDE. Declining referral volumes, procedure commoditization, and limited DSO interest.
• Implant-heavy periodontal practices: 4-6x SDE, or 6-9x EBITDA for multi-provider groups. Implant placement at $2,000-$4,000 per implant, plus bone grafting ($500-$1,500), plus guided surgery fees. A periodontist placing 15-20 implants per week generates $1.5M-$2.5M in revenue from implants alone.

The key metrics buyers evaluate in periodontal practices: implant cases per month, average implant revenue per case (including grafting and surgical guides), percentage of revenue from implants vs. traditional perio, and whether the practice has invested in guided surgery technology (like X-Guide or Yomi robotic systems).

I recently valued a two-periodontist practice in Texas that had fully pivoted to implants — 70% of revenue from implant placement and All-on-4 full-arch cases. They were averaging $3,200 per implant case and placing 120 implants per month across both providers. Revenue was $4.1M with $1.1M EBITDA. We received offers at 7-8x EBITDA from specialty DSO platforms, significantly above what a traditional perio practice would command.

Pediatric Dentistry: Unique Demographics, Medicaid Exposure

Pediatric dental practices are valued similarly to general practices — 60-80% of collections or 1.5-3x SDE for private sales, 5-8x EBITDA for DSO acquisitions — but with distinct risk factors that affect where in those ranges a practice falls.

Medicaid exposure is the elephant in the room. Pediatric practices often have 30-60% Medicaid patients, compared to 5-15% for general adult practices. Medicaid reimbursement for pediatric dental is 40-60% of commercial insurance rates in most states, and rates are set by state budgets that can change with political winds. A practice with 50% Medicaid revenue in a state with good reimbursement (like Michigan or Washington) is valued differently than the same practice in a low-reimbursement state (like Florida or Texas).

The sedation capability premium. Pediatric practices with sedation dentistry capability — whether nitrous oxide, oral conscious sedation, or in-office IV sedation — command 15-30% premiums over non-sedation practices. These practices handle the complex cases that other pediatric dentists refer out: children with severe anxiety, special needs patients, and cases requiring extensive restorative work in a single visit. A pediatric practice generating $500K+ in sedation case revenue has a referral moat similar to oral surgery.

Patient aging dynamics.Unlike adult practices where patients can stay for decades, pediatric patients age out at 16-18. This means the practice needs a constant inflow of new patients — typically 30-50 new patients per month for a healthy single-location practice. Buyers look carefully at new patient trends. Declining new patient counts in a pediatric practice are a much bigger red flag than in adult dentistry because you can't rely on your existing base.

Cross-Specialty Valuation Factors

Regardless of specialty, several factors affect valuation across the board:

Provider count is king. A solo specialist practice has the same owner-dependency problem as a solo GP — when the specialist leaves, the referral relationships may not transfer. Multi-provider practices (2-3+ specialists) are dramatically more valuable because the practice identity is separate from any individual. I routinely see 2-3x higher EBITDA multiples for multi-provider specialty groups vs. solo practices.

Surgical suite vs. treatment rooms. Practices with dedicated surgical suites — proper sterile environments, recovery areas, monitoring equipment, and anesthesia capability — are worth substantially more than practices operating out of standard dental operatories. A purpose-built surgical suite costs $200K-$500K to build out, represents a barrier to entry, and enables higher-revenue procedures.

DSO interest varies by specialty. Oral surgery attracts the most institutional interest (USOSM, OMS360, and others are actively building platforms). Endodontics is seeing growing DSO attention with players like Endo1 Partners and specialty-focused DSOs. Periodontics attracts interest primarily when the practice has a strong implant focus. Pediatric DSOs exist (ZARA Dental, Benevis/Kool Smiles) but the Medicaid exposure makes PE firms more cautious.

The Bottom Line

Dental specialty practices are not valued the same way as general practices, and each specialty has its own dynamics. Oral surgery commands the highest multiples in dentistry at 7-14x EBITDA for groups. Endodontics is solid but referral-dependent. Periodontics is bifurcating between declining traditional practices and thriving implant-focused ones. Pediatric dentistry carries unique Medicaid risk but offers strong DSO exit opportunities for the right practice.

If you're a dental specialist considering a sale, the single most important thing you can do is add a second (or third) provider. Solo specialty practices sell at a structural discount because buyers can't de-risk the transition. Multi-provider groups attract institutional capital and command the premium multiples that make an exit truly life-changing.